A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
Public ClinicalTrials.gov record NCT03354637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adolescents and Adult Subjects With Stable Patchy Alopecia Areata With Optional Long-Term Open-Label Extension
Study identification
- NCT ID
- NCT03354637
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aclaris Therapeutics, Inc.
- Industry
- Enrollment
- 129 participants
Conditions and interventions
Conditions
Interventions
- ATI-50002 high dose Drug
- ATI-50002 low dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2017
- Primary completion
- Apr 17, 2019
- Completion
- Sep 9, 2019
- Last update posted
- Jun 4, 2020
2017 – 2019
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigator Site | Encinitas | California | 92024 | — |
| Aclaris Investigator Site | Laguna Hills | California | 92653 | — |
| Aclaris Investigator Site | Redwood City | California | 94063 | — |
| Aclaris Investigator Site | Washington D.C. | District of Columbia | 20037 | — |
| Aclaris Investigator Site | Boynton Beach | Florida | 33472 | — |
| Aclaris Investigator Site | Miami | Florida | 33136 | — |
| Aclaris Investigator Site | Boston | Massachusetts | 02115 | — |
| Aclaris Investigator Site | Clinton Township | Michigan | 48038 | — |
| Aclaris Investigator Site | Warren | Michigan | 48088 | — |
| Aclaris Investigator Site | Fridley | Minnesota | 55432 | — |
| Aclaris Investigator Site | Minneapolis | Minnesota | 55455 | — |
| Aclaris Investigator Site | Omaha | Nebraska | 68144 | — |
| Aclaris Investigator Site | New York | New York | 10155 | — |
| Aclaris Investigator Site | Durham | North Carolina | 27710 | — |
| Aclaris Investigator Site | Winston-Salem | North Carolina | 27104 | — |
| Aclaris Investigator Site | Portland | Oregon | 97210 | — |
| Aclaris Investigator Site | Fort Washington | Pennsylvania | 19034 | — |
| Aclaris Investigator Site | Knoxville | Tennessee | 37922 | — |
| Aclaris Investigator Site | Nashville | Tennessee | 37215 | — |
| Aclaris Investigator Site | Austin | Texas | 78745 | — |
| Aclaris Investigator Site | Austin | Texas | 78759 | — |
| Aclaris Investigator Site | San Antonio | Texas | 78229 | — |
| Aclaris Investigator Site | San Antonio | Texas | 78745 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03354637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2020 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03354637 live on ClinicalTrials.gov.